N/A
N=148
Comparison of Ambu Auragain and I-Gel Supraglottic Airways in Adult Patients at an Ambulatory Surgery Center
Anesthesia · Surgery
Bottom Line
View on ClinicalTrials.gov: NCT04286581 ↗Enrolled (actual)
148
Serious AEs
—
Results posted
Dec 2022
Primary outcome: Primary: Oropharyngeal Leak Pressure (OLP) — 20.9; 22.6 cm H20
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- I-Gel Laryngeal Mask Airway (Device); Ambu Auragain Laryngeal Mask Airway (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Minnesota
- Primary completion
- Oct 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Oropharyngeal Leak Pressure (OLP) |
20.9; 22.6 | — |
| SECONDARY Time to Placement |
8.9; 30.4 | — |
| SECONDARY Sore Throat |
0; 0 | — |
| SECONDARY Sore Throat |
0; 0 | — |
Summary
The purpose of this study is to determine if an I-gel laryngeal mask airway (LMA) has a higher oropharyngeal leak pressure compared to an Ambu Auragain in adult patients in an ambulatory surgery center.
Eligibility Criteria
Inclusion Criteria
- undergoing outpatient ambulatory surgery under general anesthesia that is amenable to using a laryngeal mask airway
Exclusion Criteria
- non-English speaking patients
- patients with abnormal airway anatomy
Data sourced from ClinicalTrials.gov (NCT04286581). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.